Publications

Search our bibliography using the filters on the right-hand side.

Displaying 51 through 100 of 114 publications.

Jacobson E, Hicks KA, Yaylali E, Chen YH, Sansom S. Effects of reaching national HIV/AIDS strategy viral load suppression goal on HIV incidence, by race and ethnicity, in the United States. Presented at the 38th Annual North American Meeting of the Society for Medical Decision Making; October 24, 2016. Vancouver, Canada.

Yaylali E, Farnham P, Jacobson E, Allaire BT, Wagner DL, Hicks KA, Honeycutt AA, Sansom SL. Impact of improving HIV care and treatment and initiating PrEP in the US, 2015-2020. Poster presented at the 2016 Conference on Retroviruses and Opportunistic Infections (CROI); February 24, 2016. Boston, MA.

Yaylali E, Farnham PG, Hicks KA, Honeycutt A, Sansom SL, Tucker EL. Developing a dynamic compartmental model of HIV in the United States. Poster presented at the INFORMS Annual Meeting; November 3, 2015. Philadelphia, PA.

Chen YH, Yaylali E, Hicks KA, Tucker EL, Farnham PG, Sansom SL. Calibrating dynamic compartmental models of human immunodeficiency virus in the United States. Poster presented at the Society for Medical Decision Making (SMDM) 37th Annual North American Meeting; October 18, 2015. St. Louis, MO.

Hicks KA, Bowers LD. A model for developing athlete testing strategies based on the costs and benefits of doping. Presented at the 14th Annual USADA Symposium on Anti-Doping Science; October 4, 2015. Leesburg, VA.

Zarkin GA, Cowell AJ, Hicks KA, Mills MJ, Belenko S, Dunlap LJ, Keyes V. Lifetime benefits and costs of diverting substance-abusing offenders from state prison. Crime Delinq. 2015 Aug;61(6):829-50. doi: 10.1177/0011128712461904

Hicks K, Earnshaw S, McDade C, Shaw JW, Cifaldi MA. Benefit-risk analysis of adalimumab and alternative treatments for moderate to severe rheumatoid arthritis. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 13, 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A439-40.

Zarkin GA, Cowell AJ, Hicks KA, Mills MJ, Belenko S, Dunlap LJ, Houser KA, Keyes V. Benefits and costs of substance abuse treatment programs for state prison inmates: results from a lifetime simulation model. Health Econ. 2012 Jun;21(6):633-52.

Lasry A, Sansom SL, Hicks KA, Uzunangelov V. Allocating HIV prevention funds in the United States: recommendations from an optimization model. PLoS One. 2012 Jun 1;7(6):e37545.

Hicks KA, Karve S, Vlahiotis A, Frazee S, Tian Y, Earnshaw SR. Estimation of increases in direct medical expenditures associated with medication nonadherence and potential savings from increased adherence. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011. [abstract] Value Health. 2011 Nov; 14(7):A343-4.

Lasry A, Sansom SL, Hicks KA, Uzunangelov V. A model for allocating CDC's HIV prevention resources in the United States. Health Care Manag Sci. 2011 Mar 1;14(1):115-24.

Cho BH, Hicks KA, Honeycutt AA, Hupert N, Khavjou O, Messonnier M, Washington ML. A Tool for the Economic Analysis of Mass Prophylaxis Operations With an Application to H1N1 Influenza Vaccination Clinics. J Public Health Manag Pract. 2011 Jan 1;17(1):E22-8.

Zarkin GA, Cowell AJ, Hicks KA, Dunlap LJ, Belenko S, Mills MJ, Houser K, Keyes VS. Benefits and costs of alternative substance abuse treatment programs for individuals in state prisons: results from a lifetime simulation model. Presented at the International Society for the Study of Drug Policy Conference 2010; March 15, 2010. Santa Monica, CA. Previously presented at the Addiction Health Services Research Annual Conference.

Zarkin GA, Cowell AJ, Dunlap LJ, Hicks KA, Keyes VS, Mills MJ, Belenko S, Houser K. The benefits and costs of prison-based substance abuse treatment. Presented at the Federal Consortium Addressing the Substance Abusing Offender; January 2010. Washington, DC.

Hoerger TJ, Zhang P, Segel JE, Gregg EW, Venkat Narayan KM, Hicks KA. Improvements in risk factor control among persons with diabetes in the United States: evidence and implications for remaining life expectancy. Diabetes Res Clin Pract. 2009 Dec 1;86(3):225-32.

Zarkin GA, Cowell AJ, Dunlap LJ, Hicks KA, Keyes VS, Mills MJ. Benefits and costs of alternative substance abuse treatment programs for individuals in state prisons: results from a lifetime simulation model. Presented at the American Society of Criminology Annual Meeting; November 2009. Previously presented at the Addiction Health Services Research Annual conference.

Cowell AJ, Zarkin GA, Dunlap LJ, Hicks KA, Keyes VS, Mills MJ. Findings on drug use, crime, arrests, and other model outcomes from a simulation model of prison-based substance abuse treatment. Presented at the American Society of Criminology Annual Meeting; November 2009.

Hicks KA, Zarkin GA, Dunlap LJ, Cowell AJ, Mills MJ, Keyes VS. A dynamic model for estimating the costs and benefits on prison-based substance abuse treatment. Poster presented at the American Society of Criminology Annual Meeting; November 2009.

Zarkin GA, Cowell AJ, Hicks KA, Dunlap LJ, Belenko S, Mills MJ. Benefits and costs of alternative substance abuse treatment programs for individuals in state prisons: results from a lifetime simulation model. Presented at the Addiction Health Services Research Annual conference; October 2009.

Lasry A, Sansom S, Hicks KA, Uzunangelov VJ. A model for allocating HIV prevention resources in the United States. Poster presented at the National HIV Prevention Conference; August 2009.

Hoerger TJ, Zhang P, Segel JE, Gregg EW, Narayan K, Hicks KA. Improvements in risk factor control among persons with diabetes in the United States: evidence and implications for remaining life expectancy. Presented at the 7th World Conference on Health Economics; July 2009. Previously presented at the American Diabetes Association 69th Scientific Sessions.

Hoerger TJ, Zhang P, Segel JE, Gregg E, Narayan K, Hicks KA. Improvements in risk factor control among persons with diabetes in the United States: evidence and implications for remaining life expectancy. Presented at the American Diabetes Association 69th Scientific Sessions; June 2009.

Zarkin GA, Cowell AJ, Dunlap LJ, Hicks KA, Keyes VS, Mills MJ. Simulating the costs and benefits of prison-based substance abuse treatment. Presented at the Addiction Health Services Research; October 2008.

Hicks KA, Zarkin GA, Cowell AJ, Dunlap LJ, Mills MJ, Keyes VS. A DES model for estimating the costs and benefits of prison-based substance abuse treatment. Poster presented at the 2008 INFORMS Annual Meeting; October 2008.

Hicks KA, Uzunangelov VJ, Lasry A, Sansom S. Allocating CDC's HIV prevention funds. Presented at the 2008 INFORMS Annual Meeting; October 2008.

Hicks KA, Richter A. Impact of uncertainty in hiv resource allocation. Presented at the 2008 INFORMS Annual Meeting; October 2008.

Richter A, Hicks KA, Earnshaw SR, Honeycutt AA. Allocating HIV prevention resources: a tool for state and local decision making. Health Policy (New York). 2008 Sep 1;87(3):342-9.

Richter A, Hicks KA. Costs of equity in hiv prevention. Presented at the CDC NCHSTP Seminar; February 2008.

Hoerger TJ, Hicks KA, Sorensen SW, Herman WH, Ratner RE, Ackermann RT, Zhang P, Engelgau MM. The cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults. Diabetes Care. 2007 Nov 1;30(11):2874-9.

Earnshaw SR, Hicks K, Richter A, Honeycutt A. A linear programming model for allocating HIV prevention funds with state agencies: a pilot study. Health Care Manag Sci. 2007 Sep 1;10(3):239-52.

Hicks KA, Honeycutt A. A high cost to missing the mark: dealing with uncertainty in hiv prevention resource allocation. Poster presented at the Informs International Conference; July 2007.

Rein DB, Hicks KA, Wirth KE, Billah K, Finelli L, Fiore AE, Hoerger TJ, Bell BP, Armstrong GL. Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States. Pediatrics. 2007 Jan 1;119(1):e12-21.

Armstrong GL, Billah K, Rein DB, Hicks KA, Wirth KE, Bell BP. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity. Pediatrics. 2007 Jan 1;119(1):E22-9.

Sansom S, Lasry A, Hicks KA. The optimal allocation of HIV prevention dollars. Presented at the Centers for Disease Control and Prevention Division of HIV/AIDS Prevention Project Officers' Meeting; December 2006.

Hicks KA. A model for the efficient allocation of hiv prevention resources. Poster presented at the Centers for Disease Control and Prevention Division of HIV/AIDS Prevention Project Officers' Meeting; December 2006.

Hicks KA. Making use of cost-effectiveness analysis in the community planning process: methods and tools. Presented at the Centers for Disease Control and Prevention Division of HIV/AIDS Prevention Project Officers' Meeting; December 2006.

Ackermann RT, Marrero DG, Hicks KA, Hoerger TJ, Sorensen S, Zhang P, Engelgau MM, Ratner RE, Herman WH. An evaluation of cost sharing to finance a diet and physical activity intervention to prevent diabetes. Diabetes Care. 2006 Jun 1;29(6):1237-41.

Herman WH, Hoerger TJ, Hicks K, Brandle M, Sorensen SW, Zhang P, Engelgau MM, Hamman RF, Marrero DG, Ackermann DT, Ratner RE. Managing people at high risk for diabetes. Ann Intern Med. 2006 Jan 3;144(1):66-7.

Hicks KA, Honeycutt AA. Comparing children's immunization interventions: AFIX, RR, and WIC. Presented at the National Immunization Program Tuesday Seminar; January 2006.

Zarkin GA, Dunlap LJ, Hicks KA, Mamo D. Benefits and costs of methadone treatment: results from a lifetime simulation model. Health Econ. 2005 Nov 1;14(11):1133-50.

Rein DB, Hicks KA, Wirth KE, Hoerger TJ. Economics of hepatitis A immunization. Presented at the U.S. Advisory Committee on Immunization Practices; June 2005. Atlanta, GA.

Rein DB, Hicks KA, Wirth KE, Hoerger TJ. Update: economics of hepatitis A virus immunization. Presented at the ACIP Hepatitis Working Group; June 2005.

Rein DB, Hicks KA, Wirth KE, Hoerger TJ. Results of RTI's cost-effectiveness evaluation of childhood hepatitis A vaccination strategies. Presented at the U.S. Advisory Committee on Immunization Practices (ACIP); June 2005. Atlanta, GA.

Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005 Jan 1;142(5):323-32.

Hoerger TJ, Harris R, Hicks KA, Donahue K, Sorensen S, Engelgau M. Screening for type 2 diabetes mellitus: a cost-effectiveness analysis. Ann Intern Med. 2004 May 4;140(9):689-99.

Hicks KA. Operations research in action. Presented at the Expanding Your Horizons in Math, Science and Technology; March 2004. Research Triangle Park, NC.

Finkelstein EA, Hicks KA. Obesity cost calculator for employers. Presented at the 2004 National Business Group on Health Founding Board Meeting; February 2004.

Hicks KA, Honeycutt AA, Scotton C. A model for allocating HIV prevention resources in local jurisdictions. Poster presented at the Prevention Effectiveness and Health Economics Seminar at CDC; November 2003.

Sorensen SW, Hicks KA, Wirth K, Hoerger TJ, Narayan K, Saaddine J. Optimal allocation of resources based on the diabetes report card for quality care. Presented at the Institute for Operations Research and the Management Sciences Annual Meeting; October 2003.

Earnshaw SR, Wirth K, Hicks KA. Pilot test of the RTI HIV prevention resource allocation tool. Presented at the Florida Department of Health; August 2003.